Oxoid

Basingstoke, United Kingdom Founded: 1994 • Age: 32 yrs Acquired By Fisher Scientific
Microbiology products are developed for clinical and industrial applications.
Annual revenue $1.6M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Oxoid

Oxoid is a company based in Basingstoke (United Kingdom) founded in 1994 was acquired by Fisher Scientific in February 2004. Oxoid operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.

  • Headquarter Basingstoke, United Kingdom
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Oxoid A/S
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.57 M (USD)
    -74
    as on Dec 31, 2017
  • Net Profit
    $3.31 M (USD)
    -4
    as on Dec 31, 2016
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Fisher Scientific

    (Feb 11, 2004)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Oxoid

Premium access

Detailed funding history for Oxoid

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Oxoid

Oxoid has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fisher Scientific.

All
Institutional
Investor Description Founded Year Domain Location
Laboratory and production supplies and services are provided.
Locked Locked Locked
Premium access

Investor details for Oxoid

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Oxoid

Investments
Premium access

Investment portfolio details for Oxoid

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Oxoid

Premium access

Detailed financials for Oxoid

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Oxoid Comparisons

Oxoid Primary company
Description
Microbiology products are developed for clinical and industr...
Location
Basingstoke, United Kingdom
Founded Year
1994
Annual Revenue
$1.57 M (USD)
Net Profit
$3.31 M (USD)
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Oxoid

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Oxoid

Oxoid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biological reagents and antibodies are developed for life science research.
Locked Locked Locked
Developer of cell culture media and ancillary reagents for life science research
Locked Locked Locked
Proteins, antibodies, and molecular tools are manufactured for research applications.
Locked Locked Locked
Research services, reagents, and kits for biotech applications are provided.
Locked Locked Locked
Molecular diagnostic device and kits
Locked Locked Locked
Molecular biology reagents and kits are supplied for research applications.
Premium access

Detailed competitors of Oxoid

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Oxoid

Premium access

Complete news archive for Oxoid

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oxoid

Oxoid was founded in 1994.

Oxoid is headquartered in Basingstoke, United Kingdom. It is registered at Basingstoke, Hampshire, United Kingdom.

Annual revenue of Oxoid is $1.57M as on Dec 31, 2017.

Oxoid was founded in 1994 in Basingstoke, United Kingdom, and focuses on the microbiology sector. Products for research, clinical, and industrial uses are produced, including agar, LB media, reagents, and culture consumables. The company was acquired by Thermo Fisher Scientific in 2004, integrating its operations into broader scientific instrumentation and supplies. Activities are centered in the UK with global distribution.

Oxoid's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.

Oxoid has 1 investor. Key investors include Fisher Scientific.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available